Physician profile
Jacinto Manon
NPI 1326246638
$12,296.29
in general payments reported to CMS, 2019-2025
20 companies · $1,619 in 2025
The $1,619 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,016 · 2020: $284 · 2021: $2,071 · 2022: $5,380 · 2023: $941 · 2024: $985 · 2025: $1,619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,535 · Travel and Lodging: $10.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,535.03 |
| Travel and Lodging | $10.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,640.59 | 2021-2024 | Catalyft Pl Expandable Interbody System, Anteralign Spinal System With Titan Nanolock Surface Technology, Cd Horizon Spinal System |
| Abbott Laboratories | $3,692.48 | 2021-2024 | Proclaim, Penta |
| Globus Medical, INC. | $1,156.56 | 2019-2025 | Simplify Cervical Artificial Disc, Coalition Agx, X-Core |
| Baxter Healthcare | $965.04 | 2019-2025 | Perclot, Floseal |
| Si-Bone, INC. | $451.82 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $422.98 | 2019 | |
| Integra Lifesciences Corporation | $178.66 | 2019-2025 | Duraseal Exact Spinal Sealant System, Codman Certas, Cusa Clarity |
| Alafair Biosciences, INC. | $169.44 | 2025 | Versawrap |
| Genentech USA, INC. | $134.16 | 2019 | |
| Centinel Spine, LLC | $121.75 | 2022 | |
| Merck Sharp & Dohme LLC | $121.63 | 2020 | |
| Depuy Synthes Sales INC. | $57.19 | 2019-2020 | |
| Celgene Corporation | $43.37 | 2020 | |
| Novartis Pharmaceuticals Corporation | $22.23 | 2020 | |
| Orthofix Medical, INC. | $21.80 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $21.23 | 2019 | |
| Glaxosmithkline, LLC. | $19.80 | 2020 | |
| Eisai INC. | $19.75 | 2020 | |
| Jazz Pharmaceuticals INC. | $18.81 | 2021 | |
| Solventum Corporation | $17.00 | 2025 | Prevena, V.A.C.Instill, Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacinto Manon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.